These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3938459)

  • 1. [In vitro evaluation of antimicrobial removal with adsorbens].
    Okuda S; Saito A; Miyahara T; Watanabe K; Ueno K
    Kansenshogaku Zasshi; 1985 Nov; 59(11):1073-83. PubMed ID: 3938459
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved recovery of microorganisms from patients receiving antibiotics with the antimicrobial removal device.
    Peterson LR; Shanholtzer CJ; Mohn ML; Gerding DN
    Am J Clin Pathol; 1983 Nov; 80(5):692-6. PubMed ID: 6356871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-kill curves as a tool for targeting ceftazidime serum concentration during continuous infusion for treatment of septicaemic melioidosis.
    Soontornpas C; Saraya S; Chulasiri M; Chindavijak B; Mootsikapun P
    Int J Antimicrob Agents; 2005 Nov; 26(5):403-7. PubMed ID: 16216470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of combination therapy with ciprofloxacin and azlocillin in intensive care patients with pneumonia and/or sepsis.
    Engelhardt D; Ruckdeschel G
    J Chemother; 1989 Jul; 1(4 Suppl):788-9. PubMed ID: 16312640
    [No Abstract]   [Full Text] [Related]  

  • 5. Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock.
    Vazquez-Guillamet C; Scolari M; Zilberberg MD; Shorr AF; Micek ST; Kollef M
    Crit Care Med; 2014 Nov; 42(11):2342-9. PubMed ID: 25072764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations might lead to overestimation of target site activity of piperacillin in patients with sepsis.
    Zeitlinger MA; Erovic BM; Sauermann R; Georgopoulos A; Müller M; Joukhadar C
    J Antimicrob Chemother; 2005 Oct; 56(4):703-8. PubMed ID: 16120628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic removal device.
    de Silva MI
    J Natl Med Assoc; 1987 May; 79(5):472, 569. PubMed ID: 3108516
    [No Abstract]   [Full Text] [Related]  

  • 8. Simultaneous antibiotic levels in "breakthrough" gram-negative rod bacteremia.
    Anderson ET; Young LS; Hewitt WL
    Am J Med; 1976 Oct; 61(4):493-7. PubMed ID: 788512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [THE QUANTITATIVE DETERMINATION OF THE ODSORPTION POWER OF CARBO ADSORBENS].
    MUEHLEMANN H; HOFSTETTER R
    Pharm Acta Helv; 1963; 38():474-90. PubMed ID: 14052341
    [No Abstract]   [Full Text] [Related]  

  • 10. Tobramycin: clinical and microbiological evaluation.
    Schoutens E; Vanderlinden MP; Yourassowsky E
    Int J Clin Pharmacol; 1973 Nov; 8(3):207-15. PubMed ID: 4589328
    [No Abstract]   [Full Text] [Related]  

  • 11. Neonatal sepsis: looking beyond the blood culture: evaluation of a study of universal primer polymerase chain reaction for identification of neonatal sepsis.
    Decamp LR; Dempsey AF; Tarini BA
    Arch Pediatr Adolesc Med; 2009 Jan; 163(1):12-4. PubMed ID: 19124697
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the efficacy of antimicrobial therapy by determining serum bactericidal activity].
    Martino P; Venditti M; Valente B; Serra P
    G Ital Chemioter; 1981; 28(1-2):9-13. PubMed ID: 7347707
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the antimicrobial removal device].
    Liu YC; Shi FW; Cheng DL; Leu HS
    Taiwan Yi Xue Hui Za Zhi; 1984 Nov; 83(11):1178-9. PubMed ID: 6597284
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
    Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; D'Amato G; Orlando F; Sisti V; Kamysz W; Silvestri C; Naldoski P; Lukasiak J; Saba V; Scalise G
    J Antimicrob Chemother; 2004 Sep; 54(3):654-60. PubMed ID: 15294887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock.
    Borsuk-De Moor A; Rypulak E; Potręć B; Piwowarczyk P; Borys M; Sysiak J; Onichimowski D; Raszewski G; Czuczwar M; Wiczling P
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AUC-Guided Vancomycin Dosing in Adolescent Patients With Suspected Sepsis.
    Lanke S; Yu T; Rower JE; Balch AH; Korgenski EK; Sherwin CM
    J Clin Pharmacol; 2017 Jan; 57(1):77-84. PubMed ID: 27291466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and laboratory studies with tobramycin.
    Geddes AM; Goodall JA; Speirs CF; Gillett AP; Andrews J; Williams JD
    Chemotherapy; 1974; 20(4):245-56. PubMed ID: 4212996
    [No Abstract]   [Full Text] [Related]  

  • 18. The choice of antimicrobial drugs.
    Med Lett Drugs Ther; 1982 Mar; 24(604):21-8. PubMed ID: 7062892
    [No Abstract]   [Full Text] [Related]  

  • 19. The choice of antimicrobial drugs.
    Med Lett Drugs Ther; 1984 Mar; 26(656):19-26. PubMed ID: 6700533
    [No Abstract]   [Full Text] [Related]  

  • 20. Population Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care Unit.
    Abdul-Aziz MH; Abd Rahman AN; Mat-Nor MB; Sulaiman H; Wallis SC; Lipman J; Roberts JA; Staatz CE
    Antimicrob Agents Chemother; 2016 Jan; 60(1):206-14. PubMed ID: 26482304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.